Abstract

Newcastle disease virus (NDV) is the causative agent of an economically important disease, which affects all species of birds worldwide. Current vaccination programs for NDV include the use of either low-virulent live-virus vaccines or inactivated vaccines to induce protective immunity while producing minimal adverse effects in birds. In order to further characterize the immune response elicited by live virus and inactivated NDV conventional vaccines in chickens, we evaluated the presence of specific antibodies in different secretions and in tissue culture supernatants of immunized birds. To this end, we analyzed all the samples by ELISA, using an indirect assay set up in the laboratory. Specific anti-NDV IgG antibodies were detected in tracheal and cloacal swabs and tracheal and intestinal washes of immunized animals. We also found specific anti-NDV IgG antibodies in tracheal and intestinal tissue culture supernatants, indicating that the IgG found in swabs and washes was not transudated from serum or, at least, was not all transudated from serum. Knowledge about the mechanisms involved in the immune response of chickens to different NDV vaccines should increase our understanding of the mucosal response against the virus and, eventually, provide new useful information for the development and evaluation of synthetic vaccines.

Highlights

  • Newcastle disease virus (NDV), a member of the genus Avulavirus within the Paramyxoviridae family [1], causes an economically important disease in all species of birds worldwide [2]

  • IgG induced by low-virulent virus was detectable at day 7 post-vaccination, while inactivated NDV vaccine induced a detectable response from day 14 postvaccination

  • We studied the response elicited by low-virulent live-virus and inactivated vaccines against NDV in chickens, evaluating the presence of IgG in different fluids and trying to identify IgG production sites

Read more

Summary

Introduction

Newcastle disease virus (NDV), a member of the genus Avulavirus within the Paramyxoviridae family [1], causes an economically important disease in all species of birds worldwide [2]. The disease can vary from clinically inapparent to highly virulent forms depending on the virus strain and host species [2]. Virulent NDV infection is a disease notifiable to the World Organization for Animal Health [3], because it is the cause of sanitary obstacles for the trade of avian products among countries [4]. Current vaccination programs for NDV include the use of either low-virulent live-virus vaccines or inactivated vaccines to induce protective immunity while producing minimal adverse effects in birds. Inactivated oil-emulsion vaccines are manufactured for use by individual bird injection. Birds may be inoculated with eye drops containing vaccines based on attenuated viruses

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call